Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Mol Cancer Res. 2018 Jun 14;16(10):1523–1529. doi: 10.1158/1541-7786.MCR-18-0281

Table 2:

Summary of pathology from moribund Mdm2Tg mice

Mdm2Tg Mdm2TgDaxxΔ3/+

Mice n=9 (%) n=13 (%)
  Cancers 8 (89%) 11 (85%)
  Ovarian cyst 0 (0%) 1 (8%)
  No pathology 1 (11%) 2 (15%)

Tumors n=11 (%) n=13 (%)
  Lymphoma 8 (73%) 10 (77%)
  Sarcoma 1 (9%) 2 (15%)
  Carcinoma (HCC) 2 (18%) 1 (8%)